Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory phase 2 study of Kudinchoside A inhalation solution in moderate chronic obstructive pulmonary disease
CTR20240812Phase 2Active
- Sponsor
- Kaiyi Pharma
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of kudinchoside a in chronic obstructive pulmonary disease (COPD), sponsored by Kaiyi Pharma. Started Apr 2024; status: active.
02
Drugs
kudinchoside a
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20240812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240812.